Page last updated: 2024-08-24

tenofovir and osteoprotegerin

tenofovir has been researched along with osteoprotegerin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brown, TT; Labbato, D; McComsey, GA; Ross, AC; Storer, N	1
Aldrovandi, G; Chan, C; Fischer, B; Goodenow, MM; Kim-Chang, JJ; Sleasman, JW; Venturi, G; Weber, TJ; Wilson, L	1

Other Studies

2 other study(ies) available for tenofovir and osteoprotegerin

Article	Year
Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens. Antiviral therapy, 2011, Volume: 16, Issue:7 Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Biomarkers; Bone Density; Bone Remodeling; CD4 Lymphocyte Count; Collagen Type I; Cytokines; Female; HIV Infections; Humans; Inflammation; Longitudinal Studies; Male; NF-kappa B; Organophosphonates; Osteoprotegerin; Protease Inhibitors; RANK Ligand; Tenofovir; Tumor Necrosis Factor-alpha; Young Adult	2011
Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy. AIDS research and human retroviruses, 2019, Volume: 35, Issue:8 Topics: Adolescent; Alkaline Phosphatase; Anti-HIV Agents; Biomarkers; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Female; HIV Infections; Humans; Lymphocyte Activation; Macrophage Activation; Macrophages; Male; Osteopontin; Osteoprotegerin; Parathyroid Hormone; RANK Ligand; Tenofovir; Young Adult	2019

Article

Year

Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens.

Antiviral therapy, 2011, Volume: 16, Issue:7

Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Biomarkers; Bone Density; Bone Remodeling; CD4 Lymphocyte Count; Collagen Type I; Cytokines; Female; HIV Infections; Humans; Inflammation; Longitudinal Studies; Male; NF-kappa B; Organophosphonates; Osteoprotegerin; Protease Inhibitors; RANK Ligand; Tenofovir; Tumor Necrosis Factor-alpha; Young Adult

2011

Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy.

AIDS research and human retroviruses, 2019, Volume: 35, Issue:8

Topics: Adolescent; Alkaline Phosphatase; Anti-HIV Agents; Biomarkers; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Female; HIV Infections; Humans; Lymphocyte Activation; Macrophage Activation; Macrophages; Male; Osteopontin; Osteoprotegerin; Parathyroid Hormone; RANK Ligand; Tenofovir; Young Adult

2019